LBP and hyperuricemia: In the LBP (100 and 200 mg/kg) groups, the serum XOD and hepatic XODactivities were also inhibited compared with those in the hyperuricaemia group (p < 0.01, Figure4(A,B)), indicating the potential mechanism of the decreased SUA levelsin hyperuricemic mice treated with LBPs occurs by suppressing XOD activity.